A study in humans identified hsa-miR-25-5p as up-regulated in the plasma of young patients with ST-segment elevated myocardial infarction (STEMI) via small RNA sequencing, though it was not validated by subsequent qRT-PCR [Tong et al. DOI:10.3390/ijms19051467]. A separate meta-analysis in humans found hsa-miR-25-3p to be up-regulated in the saliva of patients with mild traumatic brain injury, where it was associated with specific signaling pathways [Matyasova et al. DOI:10.4149/gpb_2021038]. A study in non-human primates (Macaca mulatta) demonstrated that plasma levels of the mir-25 at or below the median abundance at day 15 post whole-thorax lung irradiation were associated with statistically significant reduced survival, correlating with late radiation injury [Rogers et al. DOI:10.1667/RADE-20-00031.1].